Stock UNICHEMLAB UNICHEM LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Unichem Laboratories Limited

Equities

UNICHEMLAB

INE351A01035

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 12:34:17 2024-05-03 am EDT 		5-day change 1st Jan Change
587.2 INR +0.38% Intraday chart for Unichem Laboratories Limited +1.92% +44.64%
Mar. 29 Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024 CI
Mar. 27 Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down MT

Business Summary

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.

Number of employees: 2,894

Sales per Business

INR in Million2022Weight2023Weight Delta
Formulations
86.2 %
10,969 86.4 % 11,582 86.2 % +5.60%
Bulk Drugs and Chemicals
10.7 %
1,511 11.9 % 1,442 10.7 % -4.59%
Other
1.7 %
119 0.9 % 230 1.7 % +93.92%
Export Benefits
1.3 %
100 0.8 % 176 1.3 % +76.18%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
60.3 %
7,343 58.8 % 7,856 60.3 % +6.98%
Others
37.2 %
4,724 37.9 % 4,846 37.2 % +2.58%
India
2.5 %
413 3.3 % 322 2.5 % -21.92%

Managers

Managers TitleAgeSince
Pabitrakumar Kalipada Bhattacharyya CEO
 Chief Executive Officer 55 23-08-09
Sandip Ghume DFI
 Director of Finance/CFO - 18-10-29
Prakash Amrut Mody CHM
 Chairman 71 77-08-21
Pradeep Bhandari CMP
 Compliance Officer - 19-07-31
Dilip Bhor IRO
 Public Communications Contact - -

Members of the board

Members of the board TitleAgeSince
Pranay Godha BRD
 Director/Board Member 51 23-08-09
Anand Trimbak Kusre BRD
 Director/Board Member 75 -
Prakash Amrut Mody CHM
 Chairman 71 77-08-21
Arun Lalchand Todarwal BRD
 Director/Board Member 66 -
Pabitrakumar Kalipada Bhattacharyya CEO
 Chief Executive Officer 55 23-08-09
Priti Puri BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 70,405,750 20,283,296 ( 28.81 %) 0 28.81 %

Shareholders

NameEquities%Valuation
IPCA LABORATORIES LIMITED
52.67 %
37,081,011 52.67 % 217 M ₹
Prakash Amrut Mody
12.78 %
8,997,952 12.78 % 53 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
7.977 %
5,616,132 7.977 % 33 M ₹
Anita Prakash Mody
1.880 %
1,323,400 1.880 % 8 M ₹
Suparna Prakash Mody
1.349 %
949,936 1.349 % 6 M ₹
Prakash Supriya Mody
1.349 %
949,936 1.349 % 6 M ₹
DSP Asset Managers Pvt. Ltd.
1.045 %
735,591 1.045 % 4 M ₹
Government of India
0.9743 %
685,989 0.9743 % 4 M ₹
Franklin Templeton Asset Management (India) Pvt Ltd.
0.9051 %
637,253 0.9051 % 4 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.3759 %
264,654 0.3759 % 2 M ₹

Company contact information

Unichem Laboratories Ltd.

Unichem Bhavan Prabhat Estate, Off. S.V. Road

400102, Mumbai

+91 22 6688 8333

http://www.unichemlabs.com
address Unichem Laboratories Limited(UNICHEMLAB)

Group companies

NameCategory and Sector
Niche Generics Ltd.
Logo Niche Generics Ltd.

Niche Generics Ltd.

Medical DistributorsDistribution Services

Niche Generics Ltd. marketed and distributed pharmaceutical products. It offered antifungal, antineoplastic, antispasmodic/anticholinergic, cardiovascular system, and central nervous system, as well as pain, analgesic, and antipyretic products. The firm products are supplied via wholesalers in the United Kingdom; sales in Europe; and selected partners to other territories. The company was founded on January 15, 2002 and was headquartered in Hitchin, the United Kingdom.

Medical Distributors

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
UNICHEM LABORATORIES LIMITED Stock Unichem Laboratories Limited
+44.64% 494M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 235B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. UNICHEMLAB Stock
  4. Company Unichem Laboratories Limited